赛德特生物制药

Scidet Bio-pharmaceutical is a Chinese biotechnology company dedicated to the development and commercialization of innovative cell therapies and regenerative medicine products. The company focuses on a diverse pipeline of immune cell therapies, including CAR-T, NK, and DC-CIK cells, as well as mesenchymal stem cell (MSC) treatments. Scidet operates a comprehensive network of GMP-compliant manufacturing facilities and regional cell banks across China, facilitating the delivery of personalized medicine. Their research programs target high-unmet-need areas such as hematological malignancies, solid tumors, and chronic degenerative diseases. By integrating R&D with large-scale production capabilities, Scidet aims to accelerate the clinical translation of advanced biotechnologies.